Roche Holding AG

Roche Holding AG, a Pharmaceutical Preparation Manufacturing company headquartered in Switzerland, is committed to addressing its carbon emissions.

In 2023, Roche's reported Scope 1 emissions were 240,266,000 kg CO2e, and Scope 2 (market-based) emissions were 98,480,000 kg CO2e. Total Scope 3 emissions for 2023 were 5,978,508,000 kg CO2e, with significant contributors including purchased goods and services at 4,525,396,000 kg CO2e, and capital goods at 433,307,000 kg CO2e.

Roche Holding AG has set ambitious Science Based Targets initiative (SBTi) approved goals. The company commits to reaching net-zero greenhouse gas emissions across its entire value chain by 2045. As near-term targets, F. Hoffmann-La Roche Ltd, as reported to SBTi, aims to reduce absolute Scope 1 and 2 GHG emissions by 70% by 2029 from a 2022 base year. Additionally, it commits to reducing absolute Scope 3 GHG emissions from fuel- and energy-related activities, waste generated in operations, and business travel by 22.5% within the same timeframe. Long-term, F. Hoffmann-La Roche Ltd commits to reducing absolute Scope 1 and 2 GHG emissions by 90% by 2045 from a 2022 base year, and absolute Scope 3 GHG emissions by 90% within the same timeframe.

Previously, Roche had a mid-term goal to reduce consumed energy from Scope 1 and Scope 2 sources per employee by 15% within its own facilities by 2025, using a 2015 baseline.